In addition to STAT3-mediated PD-L1 upregulation in cancer cells, activated STAT3 also upregulates the expression of immune checkpoint molecules on the cell surface of immune cells, including regulatory T-cells [39], B-cells [73], CD4 [74], CD8 [75], and MDSCs [29]. This evidence concerns the gene CD274 and cancer.